Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Centrosomal protein of 85 kDa (CEP85) is a coiled-coil domain-containing, centrosome-associated protein essential for efficient centriole duplication and cell cycle progression. It directly interacts with STIL to promote the early steps of centriole formation and modulates PLK4-driven cytoskeletal rearrangements and cell motility. Additionally, CEP85 acts as a negative regulator of the NEK2 kinase, maintaining centrosome integrity in non-dividing cells and suppressing centrosome disjunction. Mutations in CEP85 are linked to primary autosomal recessive microcephaly, highlighting its importance in neurodevelopment. There are currently no known drugs targeting CEP85, and it is not considered a therapeutic target in clinical practice.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Centrosomal protein of 85 kDa (CEP85).